{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,24]],"date-time":"2026-05-24T23:04:19Z","timestamp":1779663859171,"version":"3.53.1"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T00:00:00Z","timestamp":1774915200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T00:00:00Z","timestamp":1779667200000},"content-version":"vor","delay-in-days":55,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100011789","name":"Department of Science and Technology of Jilin Province","doi-asserted-by":"publisher","award":["20250206017ZP"],"award-info":[{"award-number":["20250206017ZP"]}],"id":[{"id":"10.13039\/501100011789","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Commun Biol"],"DOI":"10.1038\/s42003-026-09930-2","type":"journal-article","created":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T04:47:23Z","timestamp":1774932443000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Lisinopril activates BI1 to reprogram lipid metabolism and restore autophagy in ALS"],"prefix":"10.1038","volume":"9","author":[{"given":"Hanlan","family":"Yin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhichao","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuxiang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiyang","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueqi","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenfu","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2627-5876","authenticated-orcid":false,"given":"Fuqiang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8653-9909","authenticated-orcid":false,"given":"Linlin","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,31]]},"reference":[{"key":"9930_CR1","doi-asserted-by":"publisher","unstructured":"Tzeplaeff, L., Wilfling, S., Requardt, M. V. & Herdick, M. Current state and future directions in the therapy of ALS. Cells 12, https:\/\/doi.org\/10.3390\/cells12111523 (2023).","DOI":"10.3390\/cells12111523"},{"key":"9930_CR2","doi-asserted-by":"publisher","unstructured":"Dong, D. et al. Poly-GR repeats associated with ALS\/FTD gene C9ORF72 impair translation elongation and induce a ribotoxic stress response in neurons. Sci. Signal. 17, https:\/\/doi.org\/10.1126\/scisignal.adl1030 (2024).","DOI":"10.1126\/scisignal.adl1030"},{"key":"9930_CR3","doi-asserted-by":"publisher","unstructured":"Yang, X. et al. Amyotrophic lateral sclerosis: molecular mechanisms, biomarkers, and therapeutic strategies. Antioxidants 10, https:\/\/doi.org\/10.3390\/antiox10071012 (2021).","DOI":"10.3390\/antiox10071012"},{"key":"9930_CR4","doi-asserted-by":"publisher","unstructured":"M\u2019Angale, P. G. & Staveley, B. E. Bax-inhibitor-1knockdown phenotypes are suppressed byBuffyand exacerbate degeneration in a Drosophila model of Parkinson disease. PeerJ 5, https:\/\/doi.org\/10.7717\/peerj.2974 (2017).","DOI":"10.7717\/peerj.2974"},{"key":"9930_CR5","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1073\/pnas.1810870116","volume":"116","author":"S Wu","year":"2018","unstructured":"Wu, S., Song, W., Wong, C. C. L. & Shi, Y. Bax inhibitor 1 is a \u03b3-secretase\u2013independent presenilin-binding protein. Proc. Natl. Acad. Sci. 116, 141\u2013147 (2018).","journal-title":"Proc. Natl. Acad. Sci."},{"key":"9930_CR6","doi-asserted-by":"publisher","unstructured":"Kadivella, M. et al. Adjuvant activity of a small molecule TLR4 agonist discovered via structure-based virtual screening. Commun. Biol. 8, https:\/\/doi.org\/10.1038\/s42003-025-08582-y (2025).","DOI":"10.1038\/s42003-025-08582-y"},{"key":"9930_CR7","doi-asserted-by":"publisher","first-page":"35492","DOI":"10.18632\/oncotarget.18033","volume":"8","author":"MV Blagosklonny","year":"2017","unstructured":"Blagosklonny, M. V. From rapalogs to anti-aging formula. Oncotarget 8, 35492\u201335507 (2017).","journal-title":"Oncotarget"},{"key":"9930_CR8","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1161\/01.HYP.35.4.908","volume":"35","author":"W Linz","year":"2000","unstructured":"Linz, W., Heitsch, H., Sch\u00f6lkens, B. A. & Wiemer, G. Long-term angiotensin II type 1 receptor blockade with fonsartan doubles lifespan of hypertensive rats. Hypertension 35, 908\u2013913 (2000).","journal-title":"Hypertension"},{"key":"9930_CR9","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1016\/j.bcp.2009.06.018","volume":"78","author":"EL Santos","year":"2009","unstructured":"Santos, E. L. et al. Long term treatment with ACE inhibitor enalapril decreases body weight gain and increases life span in rats. Biochem. Pharmacol. 78, 951\u2013958 (2009).","journal-title":"Biochem. Pharmacol."},{"key":"9930_CR10","doi-asserted-by":"publisher","first-page":"44","DOI":"10.5114\/amsad\/161519","volume":"8","author":"A Leila","year":"2023","unstructured":"Leila, A., Mounir, A., Abedrrezak, K., Henni, C. & Atmene, S. Revitalizing cardiac health in chronic renal failure: the synergistic effects of angiotensin-converting enzyme inhibitors and vitamin C in modulating nitric oxide and left ventricular hypertrophy. Arch. Med. Sci. Atheroscler. Dis. 8, 44\u201352 (2023).","journal-title":"Arch. Med. Sci. Atheroscler. Dis."},{"key":"9930_CR11","doi-asserted-by":"publisher","first-page":"1619","DOI":"10.1007\/s11357-022-00716-y","volume":"45","author":"P Berkowicz","year":"2023","unstructured":"Berkowicz, P. et al. Accelerated ageing and coronary microvascular dysfunction in chronic heart failure in Tg\u03b1q*44 mice. GeroScience 45, 1619\u20131648 (2023).","journal-title":"GeroScience"},{"key":"9930_CR12","doi-asserted-by":"publisher","unstructured":"Egan, B. M., Scharf, A., Pohl, F. & Kornfeld, K. Control of aging by the renin\u2013angiotensin system: a review of C. elegans, Drosophila, and mammals. Front. Pharmacol. 13, https:\/\/doi.org\/10.3389\/fphar.2022.938650 (2022).","DOI":"10.3389\/fphar.2022.938650"},{"key":"9930_CR13","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1159\/000329327","volume":"34","author":"A Whaley-Connell","year":"2011","unstructured":"Whaley-Connell, A. et al. Angiotensin II activation of mTOR results in tubulointerstitial fibrosis through loss of N-cadherin. Am. J. Nephrol. 34, 115\u2013125 (2011).","journal-title":"Am. J. Nephrol."},{"key":"9930_CR14","doi-asserted-by":"publisher","unstructured":"Yamashiro, Y. et al. Abnormal mechanosensing and cofilin activation promote the progression of ascending aortic aneurysms in mice. Sci. Signal. 8, https:\/\/doi.org\/10.1126\/scisignal.aab3141 (2015).","DOI":"10.1126\/scisignal.aab3141"},{"key":"9930_CR15","doi-asserted-by":"publisher","first-page":"L363","DOI":"10.1152\/ajplung.00141.2005","volume":"289","author":"RI Bechara","year":"2005","unstructured":"Bechara, R. I. et al. Angiotensin II mediates glutathione depletion, transforming growth factor-\u03b21 expression, and epithelial barrier dysfunction in the alcoholic rat lung. Am. J. Physiol. Lung Cell. Mol. Physiol. 289, L363\u2013L370 (2005).","journal-title":"Am. J. Physiol. Lung Cell. Mol. Physiol."},{"key":"9930_CR16","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1001\/jamaneurol.2021.2598","volume":"78","author":"JO Johnson","year":"2021","unstructured":"Johnson, J. O. et al. Association of variants in the SPTLC1 gene with juvenile amyotrophic lateral sclerosis. JAMA Neurol. 78, 1236\u20131248 (2021).","journal-title":"JAMA Neurol."},{"key":"9930_CR17","doi-asserted-by":"publisher","first-page":"1673","DOI":"10.1038\/s41593-021-00944-z","volume":"24","author":"H Lee","year":"2021","unstructured":"Lee, H. et al. Multi-omic analysis of selectively vulnerable motor neuron subtypes implicates altered lipid metabolism in ALS. Nat. Neurosci. 24, 1673\u20131685 (2021).","journal-title":"Nat. Neurosci."},{"key":"9930_CR18","doi-asserted-by":"publisher","unstructured":"Ho, W. Y. et al. TDP-43 mediates SREBF2-regulated gene expression required for oligodendrocyte myelination. J. Cell Biol. 220, https:\/\/doi.org\/10.1083\/jcb.201910213 (2021).","DOI":"10.1083\/jcb.201910213"},{"key":"9930_CR19","doi-asserted-by":"publisher","unstructured":"Agrawal, I., Lim, Y. S., Ng, S.-Y. & Ling, S.-C. Deciphering lipid dysregulation in ALS: from mechanisms to translational medicine. Transl. Neurodegener. 11, https:\/\/doi.org\/10.1186\/s40035-022-00322-0 (2022).","DOI":"10.1186\/s40035-022-00322-0"},{"key":"9930_CR20","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1007\/s00415-010-5805-z","volume":"258","author":"J Dorst","year":"2010","unstructured":"Dorst, J. et al. Patients with elevated triglyceride and cholesterol serum levels have a prolonged survival in amyotrophic lateral sclerosis. J. Neurol. 258, 613\u2013617 (2010).","journal-title":"J. Neurol."},{"key":"9930_CR21","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1212\/01.wnl.0000285080.70324.27","volume":"70","author":"L Dupuis","year":"2008","unstructured":"Dupuis, L. et al. Dyslipidemia is a protective factor in amyotrophic lateral sclerosis. Neurology 70, 1004\u20131009 (2008).","journal-title":"Neurology"},{"key":"9930_CR22","doi-asserted-by":"publisher","first-page":"11159","DOI":"10.1073\/pnas.0402026101","volume":"101","author":"L Dupuis","year":"2004","unstructured":"Dupuis, L., Oudart, H., Ren\u00e9, F., Gonzalez de Aguilar, J. L. & Loeffler, J. P. Evidence for defective energy homeostasis in amyotrophic lateral sclerosis: benefit of a high-energy diet in a transgenic mouse model. Proc. Natl. Acad. Sci. USA 101, 11159\u201311164 (2004).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"9930_CR23","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1080\/21678421.2023.2295455","volume":"25","author":"AM Vaage","year":"2023","unstructured":"Vaage, A. M., Benth, J. \u0160, Meyer, H. E., Holm\u00f8y, T. & Nakken, O. Premorbid lipid levels and long-term risk of ALS\u2014a population-based cohort study. Amyotroph. Lateral Scler. Frontotemporal Degener. 25, 358\u2013366 (2023).","journal-title":"Amyotroph. Lateral Scler. Frontotemporal Degener."},{"key":"9930_CR24","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.jhazmat.2017.06.009","volume":"339","author":"RBD Sotto","year":"2017","unstructured":"Sotto, R. B. D. et al. Sub-lethal pharmaceutical hazard tracking in adult zebrafish using untargeted LC\u2013MS environmental metabolomics. J. Hazard. Mater. 339, 63\u201372 (2017).","journal-title":"J. Hazard. Mater."},{"key":"9930_CR25","doi-asserted-by":"publisher","first-page":"2639","DOI":"10.1104\/pp.17.01810","volume":"176","author":"M Kaling","year":"2018","unstructured":"Kaling, M. et al. Mycorrhiza-triggered transcriptomic and metabolomic networks impinge on herbivore fitness. Plant Physiol. 176, 2639\u20132656 (2018).","journal-title":"Plant Physiol."},{"key":"9930_CR26","doi-asserted-by":"publisher","unstructured":"M\u00e9ndez-L\u00f3pez, I., Sancho-Bielsa, F. J., Engel, T., Garc\u00eda, A. G. & Pad\u00edn, J. F. Progressive mitochondrial SOD1G93A accumulation causes severe structural, metabolic and functional aberrations through OPA1 down-regulation in a mouse model of amyotrophic lateral sclerosis. Int. J. Mol. Sci. 22, https:\/\/doi.org\/10.3390\/ijms22158194 (2021).","DOI":"10.3390\/ijms22158194"},{"key":"9930_CR27","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/j.coph.2009.03.007","volume":"9","author":"L Dupuis","year":"2009","unstructured":"Dupuis, L. & Loeffler, J.-P. Neuromuscular junction destruction during amyotrophic lateral sclerosis: insights from transgenic models. Curr. Opin. Pharmacol. 9, 341\u2013346 (2009).","journal-title":"Curr. Opin. Pharmacol."},{"key":"9930_CR28","doi-asserted-by":"publisher","unstructured":"Lu, Y. et al. Expression, purification and microscopic characterization of transmembrane BAX Inhibitor-1 motif containing protein 5. Protein Expr. Purif. 193, https:\/\/doi.org\/10.1016\/j.pep.2022.106045 (2022).","DOI":"10.1016\/j.pep.2022.106045"},{"key":"9930_CR29","doi-asserted-by":"publisher","unstructured":"Raoul, C. et al. Locus-specific analysis of transposable elements during the progression of ALS in the SOD1G93A mouse model. PLoS ONE 16, https:\/\/doi.org\/10.1371\/journal.pone.0258291 (2021).","DOI":"10.1371\/journal.pone.0258291"},{"key":"9930_CR30","doi-asserted-by":"publisher","first-page":"2809","DOI":"10.1073\/pnas.0506854103","volume":"103","author":"B Bailly-Maitre","year":"2006","unstructured":"Bailly-Maitre, B. et al. Cytoprotective gene bi-1 is required for intrinsic protection from endoplasmic reticulum stress and ischemia-reperfusion injury. Proc. Natl. Acad. Sci. USA 103, 2809\u20132814 (2006).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"9930_CR31","doi-asserted-by":"publisher","first-page":"7469","DOI":"10.1128\/MCB.24.17.7469-7482.2004","volume":"24","author":"JD Blais","year":"2023","unstructured":"Blais, J. D. et al. Activating transcription factor 4 is translationally regulated by hypoxic stress. Mol. Cell. Biol. 24, 7469\u20137482 (2023).","journal-title":"Mol. Cell. Biol."},{"key":"9930_CR32","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.molcel.2004.06.038","volume":"15","author":"H-J Chae","year":"2004","unstructured":"Chae, H.-J. et al. BI-1 regulates an apoptosis pathway linked to endoplasmic reticulum stress. Mol. Cell 15, 355\u2013366 (2004).","journal-title":"Mol. Cell"},{"key":"9930_CR33","doi-asserted-by":"publisher","unstructured":"Asaad, G. F., Hassan, A. & Mostafa, R. E. Anti-oxidant impact of Lisinopril and Enalapril against acute kidney injury induced by doxorubicin in male Wistar rats: involvement of kidney injury molecule-1. Heliyon 7, https:\/\/doi.org\/10.1016\/j.heliyon.2021.e05985 (2021).","DOI":"10.1016\/j.heliyon.2021.e05985"},{"key":"9930_CR34","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.29873","author":"FR Rashid","year":"2022","unstructured":"Rashid, F. R. et al. Renal effects of high-dose versus low-dose lisinopril in patients with diabetic nephropathy. Cureus https:\/\/doi.org\/10.7759\/cureus.29873 (2022).","journal-title":"Cureus"},{"key":"9930_CR35","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/j.pharmthera.2008.05.010","volume":"119","author":"KD Schl\u00fcter","year":"2008","unstructured":"Schl\u00fcter, K. D. & Wenzel, S. Angiotensin II: a hormone involved in and contributing to pro-hypertrophic cardiac networks and target of anti-hypertrophic cross-talks. Pharmacol. Ther. 119, 311\u2013325 (2008).","journal-title":"Pharmacol. Ther."},{"key":"9930_CR36","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1161\/01.CIR.103.3.448","volume":"103","author":"D Weiss","year":"2001","unstructured":"Weiss, D., Kools, J. J. & Taylor, W. R. Angiotensin II-induced hypertension accelerates the development of atherosclerosis in apoE-deficient mice. Circulation 103, 448\u2013454 (2001).","journal-title":"Circulation"},{"key":"9930_CR37","doi-asserted-by":"publisher","unstructured":"Yi, W. et al. Role of angiotensin II in aging. Front. Aging Neurosci. 14, https:\/\/doi.org\/10.3389\/fnagi.2022.1002138 (2022).","DOI":"10.3389\/fnagi.2022.1002138"},{"key":"9930_CR38","doi-asserted-by":"publisher","unstructured":"Chen, H.-H. et al. AAV-NRIP gene therapy ameliorates motor neuron degeneration and muscle atrophy in ALS model mice. Skeletal Muscle 14, https:\/\/doi.org\/10.1186\/s13395-024-00349-z (2024).","DOI":"10.1186\/s13395-024-00349-z"},{"key":"9930_CR39","doi-asserted-by":"publisher","first-page":"1653","DOI":"10.1002\/ar.24092","volume":"303","author":"A Heikkinen","year":"2019","unstructured":"Heikkinen, A., H\u00e4r\u00f6nen, H., Norman, O. & Pihlajaniemi, T. Collagen XIII and other ECM Components in the assembly and disease of the neuromuscular junction.  Anat. Rec. 303, 1653\u20131663 (2019).","journal-title":"Anat. Rec."},{"key":"9930_CR40","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1016\/j.intimp.2018.09.021","volume":"64","author":"S Saber","year":"2018","unstructured":"Saber, S., Goda, R., El-Tanbouly, G. S. & Ezzat, D. Lisinopril inhibits nuclear transcription factor kappa B and augments sensitivity to silymarin in experimental liver fibrosis. Int. Immunopharmacol. 64, 340\u2013349 (2018).","journal-title":"Int. Immunopharmacol."},{"key":"9930_CR41","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/j.cca.2005.12.012","volume":"367","author":"A Mohammadi-Karakani","year":"2006","unstructured":"Mohammadi-Karakani, A., Ghazi-Khansari, M. & Sotoudeh, M. Lisinopril ameliorates paraquat-induced lung fibrosis. Clin. Chim. Acta 367, 170\u2013174 (2006).","journal-title":"Clin. Chim. Acta"},{"key":"9930_CR42","doi-asserted-by":"publisher","first-page":"6530","DOI":"10.4049\/jimmunol.169.11.6530","volume":"169","author":"K Chen","year":"2002","unstructured":"Chen, K., Wei, Y., Sharp, G. C. & Braley-Mullen, H. Inhibition of TGF\u03b21 by anti-TGF\u03b21 antibody or lisinopril reduces thyroid fibrosis in granulomatous experimental autoimmune thyroiditis.  J. Immunol. 169, 6530\u20136538 (2002).","journal-title":"J. Immunol."},{"key":"9930_CR43","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1194\/jlr.P071639","volume":"58","author":"J Abdel-Khalik","year":"2017","unstructured":"Abdel-Khalik, J. et al. Defective cholesterol metabolism in amyotrophic lateral sclerosis. J. Lipid Res. 58, 267\u2013278 (2017).","journal-title":"J. Lipid Res."},{"key":"9930_CR44","doi-asserted-by":"publisher","first-page":"1681","DOI":"10.1212\/WNL.0b013e3181c1df1e","volume":"73","author":"A Chi\u00f2","year":"2009","unstructured":"Chi\u00f2, A. et al. Lower serum lipid levels are related to respiratory impairment in patients with ALS. Neurology 73, 1681\u20131685 (2009).","journal-title":"Neurology"},{"key":"9930_CR45","doi-asserted-by":"publisher","unstructured":"Blasco, H. et al. Lipidomics reveals cerebrospinal-fluid signatures of ALS. Sci. Rep. 7, https:\/\/doi.org\/10.1038\/s41598-017-17389-9 (2017).","DOI":"10.1038\/s41598-017-17389-9"},{"key":"9930_CR46","doi-asserted-by":"publisher","unstructured":"Marino, C. et al. The metabolomic profile in amyotrophic lateral sclerosis changes according to the progression of the disease: an exploratory study. Metabolites 12, https:\/\/doi.org\/10.3390\/metabo12090837 (2022).","DOI":"10.3390\/metabo12090837"},{"key":"9930_CR47","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1002\/ana.10312","volume":"52","author":"RG Cutler","year":"2002","unstructured":"Cutler, R. G., Pedersen, W. A., Camandola, S., Rothstein, J. D. & Mattson, M. P. Evidence that accumulation of ceramides and cholesterol esters mediates oxidative stress-induced death of motor neurons in amyotrophic lateral sclerosis. Ann. Neurol. 52, 448\u2013457 (2002).","journal-title":"Ann. Neurol."},{"key":"9930_CR48","doi-asserted-by":"publisher","first-page":"7777","DOI":"10.1523\/JNEUROSCI.0823-07.2007","volume":"27","author":"M Pehar","year":"2007","unstructured":"Pehar, M. et al. Mitochondrial superoxide production and nuclear factor erythroid 2-Related factor 2 activation in p75 neurotrophin receptor-induced motor neuron apoptosis.  J. Neurosci. 27, 7777\u20137785 (2007).","journal-title":"J. Neurosci."},{"key":"9930_CR49","doi-asserted-by":"publisher","unstructured":"Godoy-Corchuelo, J. M. et al. Lipid metabolic alterations in the ALS\u2013FTD spectrum of disorders. Biomedicines 10, https:\/\/doi.org\/10.3390\/biomedicines10051105 (2022).","DOI":"10.3390\/biomedicines10051105"},{"key":"9930_CR50","doi-asserted-by":"publisher","first-page":"1767","DOI":"10.1172\/JCI71601","volume":"125","author":"OM Peters","year":"2015","unstructured":"Peters, O. M., Ghasemi, M. & Brown, R. H. Emerging mechanisms of molecular pathology in ALS. J. Clin. Investig. 125, 1767\u20131779 (2015).","journal-title":"J. Clin. Investig."},{"key":"9930_CR51","doi-asserted-by":"publisher","unstructured":"Maatouk, L. et al. TLR9 activation via microglial glucocorticoid receptors contributes to degeneration of midbrain dopamine neurons. Nat. Commun. 9, https:\/\/doi.org\/10.1038\/s41467-018-04569-y (2018).","DOI":"10.1038\/s41467-018-04569-y"},{"key":"9930_CR52","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1080\/15548627.2021.1936359","volume":"18","author":"M Kocak","year":"2021","unstructured":"Kocak, M. et al. Targeting autophagy in disease: established and new strategies. Autophagy 18, 473\u2013495 (2021).","journal-title":"Autophagy"},{"key":"9930_CR53","doi-asserted-by":"publisher","unstructured":"Li, X. et al. Butyrate ameliorates mitochondrial respiratory capacity of the motor-neuron-like cell line NSC34-G93A, a cellular model for ALS. Biomolecules 12, https:\/\/doi.org\/10.3390\/biom12020333 (2022).","DOI":"10.3390\/biom12020333"},{"key":"9930_CR54","doi-asserted-by":"publisher","unstructured":"Parrella, E. et al. Synergistic association of resveratrol and histone deacetylase inhibitors as treatment in amyotrophic lateral sclerosis. Front. Pharmacol. 13, https:\/\/doi.org\/10.3389\/fphar.2022.1017364 (2022).","DOI":"10.3389\/fphar.2022.1017364"},{"key":"9930_CR55","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1007\/s12035-024-04313-2","volume":"62","author":"Y Wang","year":"2025","unstructured":"Wang, Y. et al. BI1 activates autophagy and mediates TDP43 to regulate ALS pathogenesis. Mol. Neurobiol. 62, 988\u20131030 (2025).","journal-title":"Mol. Neurobiol."},{"key":"9930_CR56","doi-asserted-by":"publisher","unstructured":"Heischmann, S. et al. Exploratory Metabolomics profiling in the kainic acid rat model reveals depletion of 25-hydroxyvitamin D3 during epileptogenesis. Sci. Rep. 6, https:\/\/doi.org\/10.1038\/srep31424 (2016).","DOI":"10.1038\/srep31424"},{"key":"9930_CR57","doi-asserted-by":"publisher","unstructured":"Haspel, J. A. et al. Circadian rhythm reprogramming during lung inflammation. Nat. Commun. 5, https:\/\/doi.org\/10.1038\/ncomms5753 (2014).","DOI":"10.1038\/ncomms5753"},{"key":"9930_CR58","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1038\/nature07762","volume":"457","author":"A Sreekumar","year":"2009","unstructured":"Sreekumar, A. et al. Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression. Nature 457, 910\u2013914 (2009).","journal-title":"Nature"}],"container-title":["Communications Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s42003-026-09930-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s42003-026-09930-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s42003-026-09930-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,24]],"date-time":"2026-05-24T23:00:11Z","timestamp":1779663611000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s42003-026-09930-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,31]]},"references-count":58,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["9930"],"URL":"https:\/\/doi.org\/10.1038\/s42003-026-09930-2","relation":{},"ISSN":["2399-3642"],"issn-type":[{"value":"2399-3642","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,31]]},"assertion":[{"value":"2 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"705"}}